Evaluating Diagnostic Accuracy and Cost Implications in MASLD Fibrosis Staging
As noninvasive tests (NITs) continue to replace liver biopsy in MASLD clinical practice and trials, the performance characteristics of...
Apr 282 min read
Resoundant Appoints Kay Pepin, PhD, as Chief Operating Officer
Rochester, MN – July 30, 2024 – Resoundant, Inc., a leader in the development and implementation of advanced magnetic resonance...
Jul 31, 20243 min read
Resoundant Applauds FDA Approval of Resmetirom: A Milestone for MASLD and MASH Patients
Rochester, MN – Resoundant, a Mayo Clinic company and the developer of Magnetic Resonance Elastography (MRE), is thrilled to announce the...
Mar 15, 20243 min read
Study: Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease
Colin Feuille, Swathi Kari, Roshan Patel, Rohan Oberoi, Jonathan Liu, Michael Ohliger, Mandana Khalili & Michele Tana Scientific Reports...
Jan 22, 20247 min read
Renaming NAFLD: The Importance and Implications of the Transition to MASLD
The lexicon of medicine is often filled with complex jargon, reflecting the intricacies of human health. Occasionally, these medical...
Jun 27, 20232 min read
Available Now - Resoundant Spring Newsletter
Get caught up on all-things-MRE with our spring newsletter. Read more here: https://www.resoundant.com/so/f7OVT2W4C?languageTag=en
May 31, 20231 min read